Lv1
96 积分 2022-10-24 加入
World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults
3个月前
已完结
Applications of SGLT2 inhibitors beyond glycaemic control
7个月前
已完结
Sodium–glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus
7个月前
已完结
Dietary index for gut microbiota (DI-GM) and cognitive function: NHANES findings and validation in a Hong Kong cohort with metagenomic data
9个月前
已完结
Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease – novel insights into cellular communication circuits
11个月前
已完结
Histological improvements following energy restriction and exercise: The role of insulin resistance in resolution of MASH
11个月前
已完结
Pan-PPAR agonist lanifibranor improves insulin resistance and hepatic steatosis in patients with T2D and MASLD
11个月前
已完结
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus
11个月前
已完结
Neuronal glucose sensing mechanisms and circuits in the control of insulin and glucagon secretion
11个月前
已完结
Liquiritigenin Alleviates Hepatic Metabolic Inflammation Through Regulation of Muscle–Liver Crosstalk Signal of Myonectin
11个月前
已完结
皖公网安备34019202002308
